Global Medical REIT (NYSE:GMRE - Get Free Report) updated its FY 2025 earnings guidance on Tuesday. The company provided EPS guidance of 0.890-0.930 for the period, compared to the consensus EPS estimate of 0.820. The company issued revenue guidance of -.
Analyst Ratings Changes
A number of equities research analysts have commented on the company. Robert W. Baird reduced their price target on Global Medical REIT from $10.00 to $9.00 and set a "neutral" rating on the stock in a research report on Thursday, May 8th. Wall Street Zen lowered Global Medical REIT from a "hold" rating to a "sell" rating in a research report on Thursday, May 22nd. One analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $10.44.
View Our Latest Stock Report on GMRE
Global Medical REIT Trading Down 1.0%
Shares of NYSE GMRE traded down $0.07 during trading on Friday, reaching $6.60. The company had a trading volume of 777,824 shares, compared to its average volume of 624,979. The company's fifty day moving average price is $6.75 and its 200-day moving average price is $7.45. Global Medical REIT has a 12 month low of $6.05 and a 12 month high of $10.46. The stock has a market cap of $441.40 million, a P/E ratio of 94.29, a PEG ratio of 1.12 and a beta of 1.15. The company has a quick ratio of 0.26, a current ratio of 0.26 and a debt-to-equity ratio of 1.44.
Global Medical REIT (NYSE:GMRE - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.23 EPS for the quarter, meeting the consensus estimate of $0.23. Global Medical REIT had a return on equity of 2.18% and a net margin of 7.32%. The company had revenue of $37.88 million for the quarter, compared to analyst estimates of $35.57 million. As a group, research analysts expect that Global Medical REIT will post 0.81 earnings per share for the current year.
Global Medical REIT Cuts Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 9th. Investors of record on Friday, June 20th were given a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 9.1%. Global Medical REIT's payout ratio is 857.14%.
Insider Activity at Global Medical REIT
In other Global Medical REIT news, CEO Mark Okey Decker, Jr. bought 57,332 shares of the business's stock in a transaction that occurred on Wednesday, June 25th. The shares were bought at an average price of $6.50 per share, for a total transaction of $372,658.00. Following the transaction, the chief executive officer directly owned 160,000 shares in the company, valued at approximately $1,040,000. This trade represents a 55.84% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 8.50% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Global Medical REIT
Several institutional investors and hedge funds have recently made changes to their positions in the business. Goldman Sachs Group Inc. boosted its position in shares of Global Medical REIT by 13.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 388,605 shares of the company's stock valued at $3,400,000 after purchasing an additional 45,243 shares in the last quarter. AQR Capital Management LLC boosted its position in shares of Global Medical REIT by 9.5% during the 1st quarter. AQR Capital Management LLC now owns 58,538 shares of the company's stock valued at $512,000 after purchasing an additional 5,062 shares in the last quarter. Envestnet Asset Management Inc. boosted its position in shares of Global Medical REIT by 39.5% during the 2nd quarter. Envestnet Asset Management Inc. now owns 26,617 shares of the company's stock valued at $184,000 after purchasing an additional 7,536 shares in the last quarter. Jones Financial Companies Lllp boosted its position in shares of Global Medical REIT by 23,920.0% during the 1st quarter. Jones Financial Companies Lllp now owns 24,020 shares of the company's stock valued at $210,000 after purchasing an additional 23,920 shares in the last quarter. Finally, Strs Ohio bought a new stake in shares of Global Medical REIT during the 1st quarter valued at about $95,000. Institutional investors own 57.52% of the company's stock.
Global Medical REIT Company Profile
(
Get Free Report)
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
See Also
Before you consider Global Medical REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.
While Global Medical REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access